Android app on Google Play

Jefferies Raises Price Target on DexCom (DXCM) 40% After Q4 Results

February 24, 2012 12:08 PM EST Send to a Friend
Get Alerts DXCM Hot Sheet
Price: $39.31 --0%

Rating Summary:
    10 Buy, 9 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 2 | Down: 6 | New: 3
Trade DXCM Now!
Join SI Premium – FREE
Jefferies boosted its price target DexCom (NASDAQ: DXCM) from $10 to $14 and reiterated its Buy rating following Q4 results.

The firm comments, "DXCM preannounced 4Q results of $22.4mn, reflecting a strong seasonal uptick in sensor utilization. 2012 is shaping up to be a year of investment as the company sets the stage for the Gen4 sensor launch."

FY12 EPS was trimmed from ($0.57) to ($0.72).

For an analyst ratings summary and ratings history on DexCom click here. For more ratings news on DexCom click here.

Shares of DexCom closed at $11.19 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co

Add Your Comment